• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数降低的心力衰竭患者医生遵循指南指导药物治疗的分析:一项真实世界研究

Analysis of Physician Compliance with Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Study.

作者信息

Wang Guixia, Liu Liming, Wang Xiaobo, Yu Ting, Xu Hui, Zhang Tingjun, Lin Jiafu, Luo Hao, Liu Yanxu, Jiang Lanxiang, Hu Wenlong, Hu Houxiang

机构信息

The First Affiliated Hospital, Jinan University, 510630 Guangzhou, Guangdong, China.

Infectious Department, Affiliated Hospital of North Sichuan Medical College, 2262110 Nanchong, Sichuan, China.

出版信息

Rev Cardiovasc Med. 2023 Sep 18;24(9):257. doi: 10.31083/j.rcm2409257. eCollection 2023 Sep.

DOI:10.31083/j.rcm2409257
PMID:39076379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11270074/
Abstract

BACKGROUND

Although compliance with the guideline recommendations for heart failure (HF) is associated with improved survival, the effects of medication on clinical practice often fail to meet expectations due to physician and/or patient-related reasons that are unclear. This study analyzed physicians' compliance with guideline-directed medical therapy (GDMT) based on real-world clinical data and identified risk factors of low compliance.

METHODS

This study included patients with HF, who were treated at the Affiliated Hospital of North Sichuan Medical College from July 2017 to June 2021. All patients were divided into high compliance, moderate compliance, and low compliance with GDMT groups. The proportion of patients receiving treatment in compliance with GDMT was analyzed, the relationship between compliance with GDMT and clinical outcomes was evaluated, and the risk factors of low compliance were identified.

RESULTS

Of all patients with HF included in the study, 498 (23.8%) had low compliance with GDMT, 1413 (67.4%) had moderate compliance with GDMT, and 185 (8.8%) had high compliance with GDMT. The readmission rate of patients in the moderate compliance with GDMT group was significantly higher than that in the high and low compliance groups ( = 0.028). There were no significant differences in the rates of severe cardiovascular disease among the three groups. The mortality rate of patients in the high compliance with GDMT group was significantly higher than that of the other groups ( 0.001). We found that a history of hypertension; New York Heart Association (NYHA) classification (III and IV vs. I); and abnormal heart rate, high-sensitive troponin T (hsTnT), N-terminal prohormone of brain natriuretic peptide (NT-proBNP), uric acid, and left ventricular diastolic dysfunction (LVDD) were all significantly associated with low compliance with GDMT.

CONCLUSIONS

The proportion of physicians' compliance with GDMT in treating patients with HF is low. Risk factors of low compliance include hypertension; NYHA classification (III and IV vs. I); and abnormal heart rate, hsTnT, NT proBNP, uric acid, and LVDD.

摘要

背景

尽管遵循心力衰竭(HF)指南建议与生存率提高相关,但由于尚不清楚的医生和/或患者相关原因,药物治疗对临床实践的效果往往未达预期。本研究基于真实世界临床数据分析医生对指南导向药物治疗(GDMT)的依从性,并确定低依从性的风险因素。

方法

本研究纳入2017年7月至2021年6月在川北医学院附属医院接受治疗的HF患者。所有患者分为GDMT高依从性、中度依从性和低依从性组。分析接受符合GDMT治疗的患者比例,评估GDMT依从性与临床结局的关系,并确定低依从性的风险因素。

结果

在纳入研究的所有HF患者中,498例(23.8%)对GDMT依从性低,1413例(67.4%)对GDMT中度依从,185例(8.8%)对GDMT高依从。GDMT中度依从组患者的再入院率显著高于高依从组和低依从组(P = 0.028)。三组间严重心血管疾病发生率无显著差异。GDMT高依从组患者的死亡率显著高于其他组(P < 0.001)。我们发现高血压病史、纽约心脏协会(NYHA)分级(III级和IV级 vs. I级)以及心率异常、高敏肌钙蛋白T(hsTnT)、脑钠肽前体N末端(NT-proBNP)、尿酸和左心室舒张功能障碍(LVDD)均与GDMT低依从性显著相关。

结论

医生在治疗HF患者时对GDMT的依从性比例较低。低依从性的风险因素包括高血压、NYHA分级(III级和IV级 vs. I级)以及心率异常、hsTnT、NT-proBNP、尿酸和LVDD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/48430d443c66/2153-8174-24-9-257-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/0e362832b366/2153-8174-24-9-257-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/db90890d0910/2153-8174-24-9-257-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/48430d443c66/2153-8174-24-9-257-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/0e362832b366/2153-8174-24-9-257-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/db90890d0910/2153-8174-24-9-257-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f776/11270074/48430d443c66/2153-8174-24-9-257-g3.jpg

相似文献

1
Analysis of Physician Compliance with Guideline-Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction: A Real-World Study.射血分数降低的心力衰竭患者医生遵循指南指导药物治疗的分析:一项真实世界研究
Rev Cardiovasc Med. 2023 Sep 18;24(9):257. doi: 10.31083/j.rcm2409257. eCollection 2023 Sep.
2
Early left bundle branch pacing in heart failure with mildly reduced ejection fraction and left bundle branch block.心力衰竭伴轻度射血分数降低和左束支传导阻滞时的早期左束支起搏。
Heart Rhythm. 2023 Oct;20(10):1436-1444. doi: 10.1016/j.hrthm.2023.07.063. Epub 2023 Jul 24.
3
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.从 GUIDE-IT 试验评估心力衰竭指南指导的药物治疗优化的局限性:一项随机临床试验的二次分析。
JAMA Cardiol. 2020 Jul 1;5(7):757-764. doi: 10.1001/jamacardio.2020.0640.
4
Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.射血分数降低的心力衰竭患者的低血压与指南指导的药物治疗
Int J Cardiol. 2023 Jan 1;370:255-262. doi: 10.1016/j.ijcard.2022.10.129. Epub 2022 Oct 19.
5
Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.医学治疗对射血分数降低的心力衰竭患者的预后意义。
ESC Heart Fail. 2023 Dec;10(6):3677-3689. doi: 10.1002/ehf2.14559. Epub 2023 Oct 7.
6
Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.背景药理学治疗在 ANTHEM-HF 中的应用:与新型心力衰竭治疗药物的当代试验比较。
ESC Heart Fail. 2019 Oct;6(5):1052-1056. doi: 10.1002/ehf2.12484. Epub 2019 Jul 24.
7
Efficacy, Safety and Mechanistic Impact of a Heart Failure Guideline-Directed Medical Therapy Clinic.心力衰竭指南指导药物治疗诊所的疗效、安全性及机制影响
JACC Heart Fail. 2025 Apr;13(4):554-568. doi: 10.1016/j.jchf.2024.08.017. Epub 2024 Oct 9.
8
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.肺动脉压指导心力衰竭伴射血分数降低患者的管理。
J Am Coll Cardiol. 2017 Oct 10;70(15):1875-1886. doi: 10.1016/j.jacc.2017.08.010.
9
Evaluation of a guideline directed medical therapy titration program in patients with heart failure with reduced ejection fraction.射血分数降低的心力衰竭患者指南指导下的药物治疗滴定方案评估
Int J Cardiol Heart Vasc. 2018 Nov 8;22:1-5. doi: 10.1016/j.ijcha.2018.10.003. eCollection 2019 Mar.
10
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study.基于射血分数降低的心力衰竭患者的指南导向药物治疗(GDMT)和目标N末端脑钠肽前体(NT-proBNP)评估种族和民族在治疗结局上的差异:GUIDE-IT研究分析
Prog Cardiovasc Dis. 2022 Mar-Apr;71:79-85. doi: 10.1016/j.pcad.2022.04.010. Epub 2022 Apr 29.

本文引用的文献

1
Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization.阿曼射血分数降低的心力衰竭患者的指南指导药物治疗:使用情况、未处方原因及剂量优化
Pharm Pract (Granada). 2022 Apr-Jun;20(2):2642. doi: 10.18549/PharmPract.2022.2.2642. Epub 2022 Apr 13.
2
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
3
Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation.射血分数保留的心力衰竭伴或不伴心房颤动患者中心力衰竭合并射血分数降低患者指南依从性评估。
J Korean Med Sci. 2021 Oct 18;36(40):e252. doi: 10.3346/jkms.2021.36.e252.
4
Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis.中国城市患者中心力衰竭的患病率和发病率:一项基于全国人口的分析。
Circ Heart Fail. 2021 Oct;14(10):e008406. doi: 10.1161/CIRCHEARTFAILURE.121.008406. Epub 2021 Aug 28.
5
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
6
Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.射血分数降低的真实世界心力衰竭患者的死亡率和指南指导的药物治疗。
Clin Cardiol. 2021 Sep;44(9):1192-1198. doi: 10.1002/clc.23664. Epub 2021 Aug 3.
7
Care Gaps in Adherence to Heart Failure Guidelines: Clinical Inertia or Physiological Limitations?心力衰竭指南遵循中的护理差距:临床惰性还是生理限制?
JACC Heart Fail. 2020 Sep;8(9):725-738. doi: 10.1016/j.jchf.2020.04.019. Epub 2020 Aug 12.
8
Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study.射血分数降低的心力衰竭患者门诊治疗中遵循指南指导的药物和器械治疗:ATA 研究。
Anatol J Cardiol. 2020 Jul;24(1):32-40. doi: 10.14744/AnatolJCardiol.2020.91771.
9
ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison.美国心脏病学会/美国心脏协会与欧洲心脏病学会心力衰竭指南比较:美国心脏病学会指南比较。
J Am Coll Cardiol. 2019 Jun 4;73(21):2756-2768. doi: 10.1016/j.jacc.2019.03.478.
10
Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. 医生指南遵循情况与射血分数降低的心力衰竭门诊患者的长期心力衰竭死亡率相关:QUALIFY 国际注册研究。
Eur J Heart Fail. 2019 Jul;21(7):921-929. doi: 10.1002/ejhf.1459. Epub 2019 Apr 1.